MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,891 | +1189000.0% | 9,218 | +921700.0% | 0.00% | – |
Q2 2023 | $1 | -100.0% | 1 | -100.0% | 0.00% | – |
Q1 2023 | $14,955 | -70.5% | 21,183 | -68.6% | 0.00% | – |
Q4 2022 | $50,648 | +80.9% | 67,530 | +106.4% | 0.00% | – |
Q3 2022 | $28,000 | -62.2% | 32,725 | -51.1% | 0.00% | – |
Q2 2022 | $74,000 | -66.8% | 66,878 | -66.5% | 0.00% | – |
Q1 2022 | $223,000 | +95.6% | 199,649 | +180.1% | 0.00% | – |
Q4 2021 | $114,000 | +15.2% | 71,282 | +74.5% | 0.00% | – |
Q3 2021 | $99,000 | -42.8% | 40,840 | -25.0% | 0.00% | – |
Q2 2021 | $173,000 | +2783.3% | 54,433 | +3189.0% | 0.00% | – |
Q1 2021 | $6,000 | 0.0% | 1,655 | 0.0% | 0.00% | – |
Q4 2020 | $6,000 | +20.0% | 1,655 | 0.0% | 0.00% | – |
Q3 2020 | $5,000 | 0.0% | 1,655 | 0.0% | 0.00% | – |
Q2 2020 | $5,000 | +400.0% | 1,655 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -83.3% | 1,655 | 0.0% | 0.00% | – |
Q4 2019 | $6,000 | -83.3% | 1,655 | -86.3% | 0.00% | – |
Q3 2019 | $36,000 | +16.1% | 12,104 | 0.0% | 0.00% | – |
Q2 2019 | $31,000 | – | 12,104 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |